Skip to main content

Find Clinical Trials

Home
Conditions
Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS)

Clinical trial condition

Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS)

Explore clinical trials studying Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS). Study availability and eligibility vary by location and protocol.

1 public trial 0 recruiting studies

Refine in advanced search Browse all conditions

Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS) trial results

Completed

Evaluation of Blood/Imaging Based Biomarkers, Aromatase Inhibitor Induced Musculoskeletal Syndrome

NCT03665077

Conditions: Aromatase Inhibitor Induced Musculoskeletal Syndrome (AIMSS), Breast Cancer, Breast Diseases, +5 more
Locations: University of Arizona Cancer Center Tucson, Arizona, United States

View Trial Details